Quay Pharma

Mark Powell has been appointed Scientific Manager at Quay Pharma. Dr. Powell will take on wider technical responsibility and seek to further raise the scientific profile of the company. Quay provides solid dosage development covering a broad range of formulation types including lipophilic systems, supported by the development of analytical methods for the recovery of API from lipid systems.

Dr. Powell has been with the company for nearly eight years and was previously in charge of the company’s Analytical Development Group. He has experience working in the water industry, serving as a consultant, and as a senior lecturer at Liverpool John Moores University.

“Mark’s in-depth knowledge and skills are invaluable to our client base and in his new role he will help us to consolidate and further develop our reputation and extensive range of specialist services,” said Quay Pharma’s chief executive officer Mike Rubinstein. “We are also delighted that his abilities have gained even wider recognition through his work with the RSC.”

Dr. Powell has also been elected Honorary Treasurer for the Analytical Division of the Royal Society of Chemistry (RSC). In this role, he will oversee the Analytical Chemistry Trust Fund, which helps to support research projects, provides travel grants for overseas students, and promotes an annual schools competition.